Changes in sputum eicosanoids and inflammatory markers after inhalation challenges with occupational agents

Chest

Volumn 136, Issue 5, 2009, Pages 1308-1315

  Fernández Nieto, Mar ^a   Sastre, Beatriz ^a   Sastre, Joaquín ^a   Lahoz, Carlos ^a   Quirce, Santiago ^b   Madero, Mauro ^a   Del Pozo, Victoria ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; CORTICOSTEROID DERIVATIVE; EUGENOL; FORMALDEHYDE; GAMMA INTERFERON; ICOSANOID; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 5; INTERLEUKIN 8; ISOCYANATE; LATEX; LEUKOTRIENE C4; METHACHOLINE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; EOSINOPHIL COUNT; FEMALE; HUMAN; MALE; OCCUPATIONAL ASTHMA; PRIORITY JOURNAL; SPIROMETRY; SPUTUM ANALYSIS;

EID: 70449396627     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-0103     Document Type: Article

References (47)

1. Lemiere C. Induced sputum and exhaled nitric oxide as noninvasive markers of airway inflammation from work exposures. Curr Opin Allergy Clin Immunol 2007; 7:133-137 (Pubitemid 46411512)
2. Lemiere C. The use of sputum eosinophils in the evaluation of occupational asthma. Curr Opin Allergy Clin Immunol 2004; 4:81-85 (Pubitemid 38581534)
3. Girard F, Chaboillez S, Cartier A, et al. An effective strategy for diagnosing occupational asthma: use of induced sputum. Am J Respir Crit Care Med 2004; 170:845-850 (Pubitemid 39346478)
4. Lemiere C, Chaboillez S, Trudeau C, et al. Characterization of airway inflammation after repeated exposures to occupational agents. J Allergy Clin Immunol 2000; 106:1163-1170 (Pubitemid 32006272)
5. Lemiere C, Chaboillez S, Malo J-L, et al. Changes in sputum cell counts after exposure to occupational agents: what do they mean? J Allergy Clin Immunol 2001; 107:1063-1068
6. Moscato G, Pignatti P, Yacoub MR, et al. Occupational asthma and occupational rhinitis in hairdressers. Chest 2005; 128:3590-3598
7. Fernández-Nieto M, Quirce S, Fraj J, et al. Airway inflammation in occupational asthma caused by styrene. J Allergy Clin Immunol 2006; 117:948-950
8. Quirce S, Fernández-Nieto M, del Pozo V, et al. Occupational asthma and rhinitis caused by eugenol in a hairdresser. Allergy 2008; 63:137-138 (Pubitemid 350198235)
9. Quirce S, Fernández-Nieto M, Pastor C, et al. Occupational asthma due to tampico fiber from agave leaves. Allergy 2008; 63:943-945 (Pubitemid 351832798)
10. Park H, Jung K, Kim HY, et al. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin Exp Allergy 1999; 29:1395-1401 (Pubitemid 29467964)
11. Lemière C, Romeo P, Chaboillez S, et al. Airway inflammation and functional changes after exposure to different concentrations of isocyanates. J Allergy Clin Immunol 2002; 110:641-646 (Pubitemid 35178802)
12. Mapp CE, Saetta M, Maestrelli P, et al. Mechanisms and pathology of occupational asthma. Eur Respir J 1994; 7:544-554
13. Lummus ZL, Alam R, Bernstein JA, et al. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-α by peripheral mononuclear cells of workers with occupational asthma. J Allergy Clin Immunol 1998; 102:265-274 (Pubitemid 28406916)
14. Maestrelli P, Del Prete GF, De Carli M, et al. CD8 T-cell clones producing interleukin-5 and interferon-γ in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand J Work Environ Health 1994; 20:376-381 (Pubitemid 24344655)
15. Hallstrand TS, Chi EY, Singer AG, et al. Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2007; 176:1072-1078
16. Lemiere C, Pelissier S, Tremblay C, et al. Leukotrienes and isocyanate-induced asthma: a pilot study. Clin Exp Allergy 2004; 34:1684-1689 (Pubitemid 39551520)
17. Quirce S, Marañón F, Umpiérrez A, et al. Chicken serum albumin (Gal d 5*) is a partially heat-labile inhalant and food allergen implicated in the bird-egg syndrome. Allergy 2001; 56:754-762 (Pubitemid 32681702)
18. Sastre J, Fernández-Nieto M, Novalbos A, et al. Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge. Chest 2003; 123: 1276-1279 (Pubitemid 36444388)
19. Quirce S, Fernández-Nieto M, Escudero C, et al. Bronchial responsiveness to bakery-derived allergens is strongly dependent on specific skin sensitivity. Allergy 2006; 61:1202-1208 (Pubitemid 44326357)
20. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47:25-29
21. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154:308-317 (Pubitemid 26269096)
22. Efthimiadis A, Spanevello A, Hamid Q, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J 2002; 20(suppl 37):19s-23s (Pubitemid 35024263)
23. Hadjicharalambous C, Dent G, May RD, et al. Measurement of eotaxin (CCL11) in induced sputum supernatants: validation and detection in asthma. J Allergy Clin Immunol 2004; 113:657-662 (Pubitemid 38530419)
24. Pavord ID, Ward R, Woltmann G, et al. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 1999; 160:1905-1909 (Pubitemid 30004694)
25. Macfarlane AJ, Dworski R, Sheller JR, et al. Sputum cysteinyl leukotrienes increase 24 h after allergen inhalation in atopic asthmatics. Am J Respir Crit Care Med 2000; 161:1553-1558 (Pubitemid 30329026)
26. Sastre B, Fernández-Nieto M, Mollá R, et al. Increased prostaglandin E2 levels in the airway of patients with eosinophilic bronchitis. Allergy 2008; 63:58-66 (Pubitemid 350198231)
27. Obata H, Dittrick M, Chan H, et al. Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma. Eur Respir J 1999; 13:489-495 (Pubitemid 29180153)
28. Di Franco A, Vagaggini B, Bacci E, et al. Leukocyte counts in hypertonic saline-induced sputum in subjects with occupational asthma. Respir Med 1998; 92:550-557 (Pubitemid 28162170)
29. Wanzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368:804-813
30. Gauvreau GM, Lee JM, Watson RM, et al. Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am J Respir Crit Care Med 2000; 161:1473-1478
31. Krakowiak A, Krawczyk-Adamus P, Dudek W, et al. Changes in cellular and biochemical profiles of induced sputum after allergen-induced asthmatic response: method for studying occupational allergic airway inflammation. Int J Occup Med Environ Health 2005; 18:27-33 (Pubitemid 40637712)
32. Maestrelli P, Occari P, Turato G, et al. Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin Exp Allergy 1997; 27:1291-1298
33. Hardy CL, Kenins L, Drew AC, et al. Characterization of a mouse model of allergy to a major occupational latex glove allergen Hev b 5. Am J Respir Crit Care Med 2003; 167: 1393-1399 (Pubitemid 36609725)
34. Herrick CA, Xu L, Wisnewski AV, et al. A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. J Allergy Clin Immunol 2002; 109:873-878 (Pubitemid 34499524)
35. Karagiannidis C, Akdis M, Holopainen P, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114:1425-1433 (Pubitemid 39575901)
36. Mamessier E, Milhe F, Guillot C, et al. T-cell activation in occupational asthma and rhinitis. Allergy 2007; 62:162-169 (Pubitemid 46090298)
37. Herd ZL, Bernstein DI. Antigen-specific stimulation of histamine releasing factors in diisocyanate-induced occupational asthma. Am J Respir Crit Care Med 1994; 150:988-994
38. Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765
39. Hawrylowicz CM. Regulatory T cells and IL-10 in allergic inflammation. J Exp Med 2005; 202:1459-1463 (Pubitemid 41746591)
40. Borish L, Aarons A, Rumbyrt J, et al. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996; 97:1288-1296 (Pubitemid 26192279)
41. Donnelly SC, Strieter RM, Reid PT, et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 1996; 125:191-196
42. Churchill L, Chilton FH, Resau JH, et al. Cyclo-oxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am Rev Respir Dis 1989; 140:449-459 (Pubitemid 19218364)
43. Delamere F, Holland E, Patel S, et al. Production of PGE2 by bovine cultured airway smooth muscle cells and its inhibition by cyclo-oxygenase inhibitors. Br J Pharmacol 1994; 111:983-988 (Pubitemid 24148759)
44. Melillo E, Woolley KL, Manning PJ, et al. Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1994; 149:1138-1141 (Pubitemid 24147051)
45. Pavord ID, Wong CS, Williams J, et al. Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis 1993; 148:87-90 (Pubitemid 23187223)
46. Mastalerz L, Sanak M, Gawlewicz-Mroczka A, et al. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Thorax 2008; 63:27-34
47. Manning PJ, Lane CG, O'Byrne PM. The effect of oral prostaglandin E1 on airway responsiveness in asthmatic subjects. Pulm Pharmacol 1989; 2:121-124 (Pubitemid 19241401)